2004
DOI: 10.1073/pnas.0401420101
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand

Abstract: Peroxisome proliferator-activated receptor ␥ (PPAR␥) coactivator 1␣ (PGC-1␣) is a transcriptional coactivator that is a key component in the regulation of energy production and utilization in metabolic tissues. Recent work has identified PGC-1␣ as a strong coactivator of the orphan nuclear receptor estrogen-related receptor ␣ (ERR␣), implicating ERR␣ as a potential mediator of PGC-1␣ action. To understand the role of ERR␣ in PGC-1␣ signaling, a parallel approach of high-throughput screening and gene-expression… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

7
153
0

Year Published

2005
2005
2015
2015

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 180 publications
(160 citation statements)
references
References 40 publications
7
153
0
Order By: Relevance
“…These receptors all share an extended half-site motif TCAAGGTCA and can bind as monomers, dimers or heterodimers ). Because these receptors have very small ligand biding pockets, endogenous ligand discovery remains unlikely, although synthetic ligands have been developed and ERRα is blocked by diethylstilbestrol, while ERRβ and γ are blocked by tamoxifen (Coward et al 2001;Greschik et al 2002;Willy et al 2004). The activity of ERRs appears to be constitutive, with the ligand binding pocket stably arranged in an active conformation without ligand (Xie et al 1999;Greschik et al 2002;Greschik et al 2004).…”
Section: Errsmentioning
confidence: 99%
“…These receptors all share an extended half-site motif TCAAGGTCA and can bind as monomers, dimers or heterodimers ). Because these receptors have very small ligand biding pockets, endogenous ligand discovery remains unlikely, although synthetic ligands have been developed and ERRα is blocked by diethylstilbestrol, while ERRβ and γ are blocked by tamoxifen (Coward et al 2001;Greschik et al 2002;Willy et al 2004). The activity of ERRs appears to be constitutive, with the ligand binding pocket stably arranged in an active conformation without ligand (Xie et al 1999;Greschik et al 2002;Greschik et al 2004).…”
Section: Errsmentioning
confidence: 99%
“…Although ERRα is an orphan nuclear receptor with no known endogenous ligand, the drug XCT790 acts as an inverse agonist to counteract the constitutive activity of ERRα (31). To complement the analysis using shRNA knockdown of ERRα, the effect of XCT790 on ADwt production was investigated.…”
Section: Pharmacological Inhibition Of Errα Is Detrimental To Hcmv Rementioning
confidence: 99%
“…Although not regulated by natural ligands, ERR␣ can be deactivated by the synthetic molecule XCT790 (11,12). ERR␣ regulates fatty acid oxidation and the adaptive bioenergetic response (13,14).…”
mentioning
confidence: 99%
“…BONNELYE ET AL tween ERR␣ and the transcriptional coactivator, peroxisome proliferator-activated receptor ␥ coactivator 1␣ (PGC-1␣) (12). PGC-1␣ exhibits differential expression during chondrocyte differentiation and modulates SOX9 activity (26).…”
mentioning
confidence: 99%